Table 1.
Descriptive Dataa
| PRP Group (n = 15) | Corticosteroid Group (n = 16) | P | |
|---|---|---|---|
| Age, y | 51.3 ± 10.3 | 62.4 ± 10.5 | .006 |
| Male sex, n (%) | 3 (20.0) | 3 (18.8) | ≥.999 |
| Body mass index | 25.1 ± 4.1 | 24.6 ± 3.6 | .719 |
| Pain duration, mo | 8.3 ± 11.6 | 13.5 ± 12.5 | .901 |
| Some strenuous work (lifting in daily routine), n (%) | 9 (60.0) | 10 (62.5) | .88 |
| Underlying diseases, n (%)b | 4 (26.7) | 3 (18.8) | .613 |
| Hypertension | 3 (20.0) | 3 (18.8) | .933 |
| Dyslipidemia | 1 (6.7) | 2 (12.5) | .598 |
| Migraine | 1 (6.7) | 0 (0.0) | .310 |
| Benign prostate hyperplasia | 1 (6.7) | 0 (0.0) | .310 |
| Nondominant arm, n (%) | 3 (20.0) | 2 (12.5) | .585 |
a Data are reported as mean ± SD unless otherwise indicated. Bolded P value indicates a statistically significant difference between groups. PRP, platelet-rich plasma.
bTwo patients had 2 underlying diseases.